Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Although inflammation is frequently a cause of disease in the body, research from The University of Texas Health Science Center at San Antonio indicates that low levels of a pro-inflammatory cytokine in the brain are important for cognition. Cytokines are proteins produced by the immune system.
Jennifer Donegan, graduate student, and David Morilak, Ph.D., professor of pharmacology in the School of Medicine, found that neutralizing the cytokine interleukin-6 in the brain impaired reversal learning in both stressed and nonstressed rats. Reversal learning is a form of cognitive flexibility that is diminished in psychiatric diseases such as depression, schizophrenia and post-traumatic stress disorder. Cognitive flexibility is the ability to change previously learned thoughts and behaviors in response to changes in the environment.
"When we started the project, we thought cognitive flexibility would be impaired by stress-induced inflammation in a region of the brain called the prefrontal cortex," Donegan said. "We decided to block interleukin-6 during stress to prevent the cognitive deficit, and to our surprise this made things worse. This suggested that it may actually be beneficial to maintain a low level of this pro-inflammatory cytokine in the brain."
As a key next step, the scientists were then able to fix the cognitive deficit caused by stress by restoring a low level of the cytokine specifically in the prefrontal cortex. Both scientists caution, however, that there is still much to learn about interleukin-6's role in cognition and in diseases like depression. "We've replicated just one piece of a very complex disease so we can understand the biology," Dr. Morilak said. "We found that, in one brain region, one cytokine facilitates cognitive flexibility and is beneficial after chronic stress. But we delivered the cytokine specifically into that brain region using a virus, which we cannot do in people. And its role in inflammation may be very different than in normal conditions. There's still a lot of work to do."
Donegan is on track to receive her Ph.D. later this year. She is lead author and Dr. Morilak is senior author of the study, published this month in the Journal of Neuroscience. The research is funded by the National Institute of Mental Health and the Brain & Behavior Research Foundation.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Psychology / Psychiatry category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Texas Health Science Center at San A. "Cognition improved by low levels of pro-inflammatory agent in rat model." Medical News Today. MediLexicon, Intl., 31 Jan. 2014. Web.
24 Apr. 2014. <http://www.medicalnewstoday.com/releases/271888>
University of Texas Health Science Center at San A. (2014, January 31). "Cognition improved by low levels of pro-inflammatory agent in rat model." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271888.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.